66 completed. 66 Phase 2, 26 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 66 | Completed 66 |
| Phase 1 | 26 | Completed 26 |
| Phase 3 | 6 | Completed 6 |
Follow Hypoxia: new trials by email Literature Review of Hypoxia trials Research Report on Hypoxia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COMBO Endoscopy Oropharyngeal Airway in Sedated Fiberoptic Bronchoscopy for Patients: A Simon Two-Stage Trial the COMBO Endoscopy Oropharyngeal Airway - Pulmonary Infection, Pulmonary Nodule | Phase 2 | Completed | Zhejiang University | 104 | 2025-06-23 | 2026-02-24 |
| To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU. Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension | Phase 1 / Phase 2 | Completed | Ziauddin University | 100 | 2025-03-12 | 2025-07-31 |
| COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients the COMBO Endoscopy Oropharyngeal Airway - Hypoxia, Esophageal Cancer | Phase 2 | Completed | Zhejiang University | 107 | 2025-02-04 | 2025-05-21 |
| Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation - Hypoxia, Esophageal Cancer | Phase 2 | Completed | Zhejiang University | 50 | 2025-02-04 | 2025-06-25 |
| Oxygen Targets in Acute Heart Failure With Pulmonary Congestion Oxygen - Acute Heart Failure, Pulmonary Congestion | Phase 2 / Phase 3 | Completed | Copenhagen University Hospital, Hvidovre | 135 | 2024-02-01 | 2026-10-26 |
| Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial) Dexmedetomidine Hydrochloride, Morphine Sulfate - Hypoxic-Ischemic Encephalopathy, Pain | Phase 2 | Completed | University of Utah | 50 | 2022-06-20 | 2026-03-06 |
| Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug | Phase 1 / Phase 2 | Completed | Radboud University Medical Center | 29 | 2022-02-22 | 2023-07-21 |
| Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior Single Arm, Neonatal Neurobehavioral Scale - Congenital Heart Disease in Children, Hypoxia | Phase 2 / Phase 3 | Completed | University of Utah | 104 | 2021-12-17 | 2026-07-14 |
| Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia Inhaled Low molecular weight heparin, Standard Treatment - COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia | Phase 2 / Phase 3 | Completed | Istanbul University | 80 | 2021-02-03 | 2021-08-05 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects Trans Sodium Crocetinate, Normal saline - SARS-CoV-2 (Covid19) | Phase 1 / Phase 2 | Completed | Diffusion Pharmaceuticals Inc | 25 | 2020-09-10 | 2022-04-14 |
| The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During Exercise in Hypoxia Nitric Oxide, Placebo - Hypoxia | Phase 1 / Phase 2 | Completed | University of Alberta | 20 | 2020-08-17 | 2024-09-19 |
| Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement Nitric Oxide-Sessions, Nitric Oxide-Continuous and Sessions - Hypoxemia, Pneumonia, Viral | Phase 1 / Phase 2 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 20 | 2020-07-24 | 2026-10-21 |
| Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019) Dornase Alfa Inhalation Solution [Pulmozyme] - COVID-19 (Coronavirus Disease 2019), Hypoxia | Phase 2 | Completed | University College, London | 41 | 2020-06-16 | 2025-01-13 |
| Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure Zilucoplan®, Placebo - COVID-19 | Phase 2 | Completed | University Hospital, Ghent | 81 | 2020-05-22 | 2023-09-14 |
| Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation L-ascorbic acid - COVID-19, Hypoxia | Phase 1 / Phase 2 | Completed | Hunter Holmes Mcguire Veteran Affairs Medical Center | 20 | 2020-04-16 | 2022-02-25 |
| Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients Whole-brain radiotherapy - Phase II Clinical Trial, Ninety-six Histologically Confirmed NSCLC Patients With BM | Phase 2 | Completed | Instituto Nacional de Cancerologia de Mexico | 96 | 2020-03-01 | 2020-04-22 |
| A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy HB-adMSCs - Traumatic Brain Injury | Phase 1 / Phase 2 | Completed | Hope Biosciences LLC | 24 | 2020-01-01 | 2026-11-09 |
| Measuring Blood Flow in the Brain After Epileptic Activity Paracetamol, Nimotop - Epilepsy, Depression | Phase 2 | Completed | Rijnstate Hospital | 34 | 2019-12-05 | 2023-11-18 |
| The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia Oxygen - Oxygen Deficiency, Pulmonary Arterial Hypertension | Phase 2 | Completed | Heidelberg University | 20 | 2019-04-01 | 2024-06-20 |
| Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury Caffeine, AIH, Placebo - Spinal Cord Injuries | Phase 1 / Phase 2 | Completed | Spaulding Rehabilitation Hospital | 36 | 2019-01-01 | 2023-12-13 |
Showing 20 of 66. Sign in to see all of them.
Hypoxia-Ischemia, Brain (20) · COVID-19 (5) · Hypothermia (5) · Lung Neoplasms (5) · Stroke (4) · Asphyxia (3) · Asphyxia Neonatorum (3) · Brain Injuries, Traumatic (3) · Head and Neck Neoplasms (3) · Hypoxia, Brain (3) · Lymphoma, Follicular (3) · Pneumonia (3) · Seizures (3) · Acute Lung Injury (2)
Pathological Conditions, Signs and Symptoms (66) · Signs and Symptoms (66) · Signs and Symptoms, Respiratory (66) · Nervous System Diseases (30) · Central Nervous System Diseases (29) · Brain Diseases (28) · Cardiovascular Diseases (26) · Respiratory Tract Diseases (26) · Vascular Diseases (26) · Cerebrovascular Disorders (23) · Brain Ischemia (21) · Lung Diseases (20) · Hypoxia, Brain (19) · Neoplasms (12)
Saline Solution (4) · Sodium Chloride (3) · Hypothermia, Induced (2) · Lasers, Gas (2) · Oxygen (2) · 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol (1) · 5-hydroxymethylfurfural (1) · Acetaminophen (1) · Albuterol (1) · Amantadine (1) · Aminophylline (1) · Ascorbic Acid (1) · Bumetanide (1) · Caffeine (1) · Celecoxib (1)
University of Utah (3) · Zhejiang University (3) · Colorado State University (2) · Great Ormond Street Hospital for Children NHS Foundation Trust (2) · Radboud University Medical Center (2) · Siemens Molecular Imaging (2) · University Hospitals Bristol and Weston NHS Foundation Trust (2) · University of Alberta (2) · Zhengzhou University (2) · Bayside Health (1) · Centre Henri Becquerel (1) · Chang Gung Memorial Hospital (1) · Copenhagen University Hospital, Hvidovre (1) · Diffusion Pharmaceuticals Inc (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)
United States (19) · China (7) · United Kingdom (7) · France (4) · Netherlands (4) · Canada (3) · Egypt (3) · Australia (2) · Germany (2) · Israel (2) · Sweden (2) · Uganda (2) · Belgium (1) · Denmark (1) · Greece (1)
Changlian Zhu, MD, PhD (2) · Christopher Bell, PhD (2) · Mariana Baserga, MD (2) · Marianne Thoresen, Professor (2) · Adrian Streinu Cercel, MD (1) · Alan C Perkins, PhD (1) · Alan Waxman, MD (1) · Ashley Bjorklund, MD (1) · Asma Abdus Salam, Consultant anaesthesiology (1) · Ayca Yildiz-Pekoz, PhD (1) · Bart N Lambrecht, MDPhD (1) · Brian C Davis, MD (1) · Charles S Cox, MD (1) · Christina I. Olofsson, MD, PhD (1)
PMID 24524452, PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 15607598, PMID 15607599, PMID 15683820, PMID 17122578, PMID 17893459, PMID 18708248, PMID 19834012, PMID 19854090, PMID 20385632, PMID 20576632, PMID 21195036, PMID 21852153, PMID 22091288, PMID 22805873, PMID 22950861, PMID 23372884, PMID 23682548, PMID 23897243, PMID 24815497, PMID 25512461, PMID 25765333, PMID 25794112, PMID 26156116, PMID 26680684, PMID 28329240, PMID 28606907, PMID 29028696, PMID 29261883, PMID 29800014, PMID 29866165, PMID 30207593, PMID 30573962, PMID 30661082, PMID 30679288, PMID 31155392, PMID 31261373, PMID 32399752, PMID 33213529, PMID 33415555, PMID 34667360, PMID 35157994, PMID 35436940, PMID 35836147, PMID 35841234, PMID 35945604
2014 (1), 2017 (1), 2018 (1), R01HD038600 (1), R01HD081274 (1), R01NS038062 (1), R01NS061860 (1), U24HL135691 (1)